Department of Clinical Laboratory, Kyoto University Hospital

[1354 / 5D325]
Japanese
 
Ver.16
5.Immunological Test >> 5D.Tumor Related Antigens>>5D325 cytokeratin 19 fragment

cytokeratin 19 fragment

[serum]

JAB

Standard Code (JLAC10)

1 Analyte5D325cytokeratin 19 fragment
Identification0000
Specimen023serum
Method053electro chemiluminescent immunoassay (ECLIA)
Result Identifying 0100
Result Identifying 0200

ISO15189 Applied Scope of Accreditation

RML00280 Non-Basic Series (October 26, 2019 revised)
Cytokeratin 19 fragment
Medical Laboratory Accreditation Certificate
Japan Accreditation Board

Specimen

Top Colour Collected Sample Quantity Measured Material Required
HotPink Top blood 6 mL serum

Specimen Rejection Criteria

haemolysis 
clotted 
lipaemia 
inappropriate sample volumereject
wrong containerreject
urine samples without the appropriate preservative 
received ambient 
unprotected from light 
opening tubes 
incterus 

Specimen Stability Information

Specimen Type Container Temperature Stability
serum Ambient 7 days
Refrigerated 30 days
Frozen 6 months

Turnaround Time (TAT)

same day / 1 to 2 days

Laboratory

Central Laboratoryweekday (8:30 a.m. - 5:00 p.m.)
night time or weekend

Reference Value

Period / Age
Specimenblood
Methodelectro chemiluminescent immunoassay (ECLIA)
  MaleFemaleUnit
00reference interval≤ 2.8≤ 2.8ng/mL
00cut off value3.53.5ng/mL
Specimenblood
Methodelectro chemiluminescent immunoassay (ECLIA)
  MaleFemaleUnit
00reference interval< 2.2< 2.2ng/mL
00cut off value< 3.5< 3.5ng/mL
Specimenblood
Method 
  MaleFemaleUnit
00cytokeratin 19 fragment< 2.0< 2.0ng/mL
Specimen
Method
  MaleFemaleUnit
Specimen
Method
  MaleFemaleUnit
Specimen
Method
  MaleFemaleUnit
Specimen
Method
  MaleFemaleUnit
Specimen
Method
  MaleFemaleUnit

Critical Value

High Value Low Value
Kyoto University Hospital
Kyoto University